To our knowledge, the present study is the first to show higher levels of plasma FGF-23 in patients with higher SMI neo-vessel count and IPN visual grades as a sign of plaque instability, more clearly linking FGF-23 levels to plaque destabilization of carotid atherosclerosis. This evidence concerns the gene FGF23 and bile duct papillary neoplasm.